The Impact of Very Late Antigen 4 Polymorphism on Drug Responsiveness in Patients with Multiple Sclerosis Initiation. (2022). Iraqi Journal of Medical Sciences, 20(1). https://iraqijms.net/index.php/jms/article/view/818